1672665-49-4
Chemical Structure
PT-2385
- CAS No.: 1672665-49-4
- Formula:C17H12F3NO4S
- Molecular Weight:383.34
IUPAC Name: (S)-3-((2,2-difluoro-1-hydroxy-7-(methylsulfonyl)-2,3-dihydro-1H-inden-4-yl)oxy)-5-fluorobenzonitrile
InChIKey: ONBSHRSJOPSEGS-INIZCTEOSA-N
SMILES: N#CC1=CC(F)=CC(OC2=CC=C(S(=O)(C)=O)C3=C2CC(F)(F)[C@H]3O)=C1
Biological Activity: PT-2385 is a selective HIF-2α inhibitor with a Ki of less than 50 nM[1][2].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
PT-2385 | 99.95% | PT-2385 is a selective HIF-2α inhibitor with a Ki of less than 50 nM. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
- [1]. Eli Wallace, Ph.D. PT2385: HIF-2α Antagonist for the Treatment of VHL Mutant ccRCC. 12th International VHL Medical Symposium April 8, 2016.
- [2]. Xie C, et al. Activation of intestinal hypoxia-inducible factor 2α during obesity contributes to hepatic steatosis. Nat Med. 2017 Nov;23(11):1298-1308. [Content Brief]
Keywords